Status:
COMPLETED
Treatment of Bacterial Vaginosis (BV) With Tinidazole
Lead Sponsor:
University of Alabama at Birmingham
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Bacterial Vaginosis
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
We are trying to determine if treatment of bacterial vaginosis with tinidazole is better than treatment with metronidazole
Detailed Description
Bacterial vaginosis (BV) is the most prevalent cause of symptomatic vaginal discharge in the U.S. and has been associated with complications including preterm delivery of infants, pelvic inflammatory ...
Eligibility Criteria
Inclusion
- Women be at least 18 years of age
- Have symptoms of vaginal odor and or/discharge
- Meet the clinical (Amsel) criteria for BV
- Willing to participate in research
Exclusion
- Presence of another vaginal infection or STD
- Allergy to metronidazole
- Pregnant or nursing
- Use of oral or intravaginal antibiotics within the past 2 weeks
- HIV or other chronic disease
- Inability to keep return appointments
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2009
Estimated Enrollment :
593 Patients enrolled
Trial Details
Trial ID
NCT00334633
Start Date
November 1 2004
End Date
December 1 2009
Last Update
December 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jefferson County Department of Health STD Clinic
Birmingham, Alabama, United States, 35294